Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Nagarkar R, Patil D, Limaye S, Devhare P, Ghaisas A, Srivastava N, Apurwa S, Patil S, John J, Raazi Z, Shreenivas A, Sambath J, Srinivasan A, Kumar P, Akolkar D, Datar R. Nagarkar R, et al. Oncotarget. 2020 Nov 10;11(45):4195-4200. doi: 10.18632/oncotarget.27793. eCollection 2020 Nov 10. Oncotarget. 2020. PMID: 33227091 Free PMC article.
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Nagarkar R, Patil D, Limaye S, Devhare P, Ghaisas A, Srivastava N, Apurwa S, Patil S, John J, Raazi Z, Shreenivas A, Sambath J, Srinivasan A, Kumar P, Akolkar D, Datar R. Nagarkar R, et al. Oncotarget. 2022 Nov 2;13:1215. doi: 10.18632/oncotarget.28296. Oncotarget. 2022. PMID: 36342460 Free PMC article. No abstract available.
Treatment with nanosomal paclitaxel lipid suspension versus conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical study.
Satheesh CT, Taran R, Singh JK, Shrivastav SP, Vithalani NK, Mukherjee KK, Nagarkar RV, Maksud T, Mehta AO, Srinivasan K, Vikranth M, Sonawane SR, Ahmad A, Sheikh S, Ali SM, Patel R, Paithankar M, Patel L, Rajani A, Bunger D, Chaturvedi A, Ahmad I. Satheesh CT, et al. Among authors: nagarkar rv. Ther Adv Med Oncol. 2024 Apr 25;16:17588359241236442. doi: 10.1177/17588359241236442. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38680290 Free PMC article.
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study.
Ahn MJ, Bondarenko I, Kalinka E, Cho BC, Sugawara S, Gálffy G, Shim BY, Kislov N, Nagarkar R, Demedts I, Gans SJM, Mendoza Oliva D, Stewart R, Lai Z, Mann H, Shi X, Hussein M. Ahn MJ, et al. Among authors: nagarkar r. J Thorac Oncol. 2023 Nov;18(11):1594-1606. doi: 10.1016/j.jtho.2023.06.013. Epub 2023 Jun 29. J Thorac Oncol. 2023. PMID: 37390980 Free article. Clinical Trial.
A case report of high-grade astroblastoma in a young adult.
Bhalerao S, Nagarkar R, Adhav A. Bhalerao S, et al. Among authors: nagarkar r. CNS Oncol. 2019 Mar;8(1):CNS29. doi: 10.2217/cns-2018-0012. Epub 2019 Feb 28. CNS Oncol. 2019. PMID: 30813777 Free PMC article.
Oral malignancy and its fickle blow off: A retrospective study.
Nagarkar R, Wagh A, Kokane G, Roy S, Palawe V, Kulkarni N, Pawar S. Nagarkar R, et al. J Cancer Res Ther. 2019 Jul-Sep;15(3):604-607. doi: 10.4103/jcrt.JCRT_188_18. J Cancer Res Ther. 2019. PMID: 31169227 Free article.
64 results